SRC:MixSentence, IDs:1CB5D976;485FA936;3AD5669B;AF24C528;430C4AF5;DE757C7F;4F45A2FE;24F2A662;99219F16;FC8C0D50;63624C40;F78D37A9;1F46BF33;4F03F29E;C54A2492;1FADB78C;0ECB4049;04EFBA12;6B520626;E73F66B8;EA15627F;F3096291;39C9A45B;CEC0943E;C0692D6E;48263096;62457DA4
If this is where clinical research is headed, that would be a terrible negative trajectory," he said. Dr. Topol - who drew attention last year with a finding that Celebrex and its competitor, Vioxx, appeared to raise the risk of heart attacks - said the Bextra studies did not include enough patients to justify drawing a broad conclusion. The average age of patients in the study, 23, did not represent the population likely to take the drug, he added. Yet through publication in the leading dental journal, the research helped Bextra's marketers shift attention away from the F.D.A.'s negative findings. Because of confidentiality rules, the F.D.A. cannot release any information about the earlier pain studies that failed to sway regulators. "Even though the study lacked some important proof, the real problem is that in the dental literature, this will be read," Dr. Topol said. "And dentists, who have to deal with trying to prevent or modulate pain, will be impressed." Judy Glova, a spokeswoman for Pharmacia, said the drug company stood behind the design and conclusions of the Scirex studies. Pharmacia was not trying to bypass the regulatory process, she said, adding that the company is in discussions with regulators to have Bextra approved for acute pain. Scirex executives did not return repeated phone calls. Editors at The Journal of the American Dental Association said the Scirex free article was reviewed by at least three scientists. One reviewer, Dr. Paul A. Moore, an associate editor of the journal, said the study was "carefully designed and rigorously performed." But Dr. Moore said he would have recommended that the journal reject the paper had he known that Bextra was not approved for acute pain. The Bextra episode is just one example of the changing face of drug research. In the early 1990's, about 75 percent of the drug industry's clinical research dollars went to universities, according to a study by CenterWatch, a company that tracks clinical trials. By 2000, just 34 percent went to academic institutions, while the rest went to investigators working under the direction of either a private research firm like Scirex or a pharmaceutical company. Omnicom says it has no control over Scirex. "We have nothing to do with the design of clinical studies," said Pat Sloan, an Omnicom spokeswoman. Yet when the ad agency paid $20 million for part-ownership of Scirex in 1999, a top Omnicom executive, Thomas L. Harrison, said he expected Scirex's research to produce positive results for drug company clients - results that would help speed new-drug applications, or N.D.A.'s, to the F.D.A. "Our goal," he said, "is to help ensure that all clinical studies and each patient accrued into a study can be assessed to support the N.D.A.

SRC:MixSentence, IDs:1BB88423;4001EF39;C802490F;9A33BE9E;C78F31F6;C6F0668D;F97F1B21;AD2F6436;B939E939;75B58E06;24F0BE8E;D70F9551;AA48DA5E;B8DD8A69;AC3A313C;3EEB98CB;7B5B1B10;394A748A;63624C40;0ECB4049;BF1C8051;E504825E;7366FF1E;5D6BC154;59BFF157;51287346;C9571794;4BCDBA06;F3096291;CE505E59;3F3E5ECC;C54A2492;DCA74BA0;CCD53EC3;9C9F8712;24F2A662;8CDB195E;A50CA055;56E21973;938DDB5B;C0692D6E;9E236019;8076E0A7;7C87789A;98BF5BC1;F7B5ECF5;0F354E03;8A521820;46FF3628;723A698E
These tools streamline registration, simplify data collection, and give audiences quick access to essential details. Content Snare helps you collect accurate data and files from clients in record time. If you cherished this short article and you would like to receive additional information concerning solicitors kindly take a look at our own internet site. Now is the time to book your training for EOFY. Any time that someone in your area uses Google to search for the services your firm provides, they will be targeted with your ads. Shouse Law Group also uses its channel to answer common legal questions, providing a valuable resource to viewers and positioning itself as an authoritative figure in its practice areas. Welcome to the Blue Knot Professional Community - connect with us here for resources, training, trauma-informed supervision and reflective practice as an individual or an organisation. Our new calendar is full of opportunities from foundational awareness to responsive leadership all focused on understanding the impacts of trauma and building skills in trauma-attuned practice. It is useful to know if disability awareness training has been successful. The Reporting it Right guidelines have been developed to assist journalists and communications professionals to portray people with a disability both sensitively and appropriately. Reporting it Right guidelines for portraying people with a disability (word). Conclusion: Patients do have the right to pain management, but patient rights have limits, which may interfere with other competing rights, and also rights of their physicians.

techdirt.comTranslations are provided in and from over 14 languages. Derek Sivers presents actionable and powerful concepts that can be applied in an enjoyable manner to almost any business. By utilizing social media platforms to connect with potential clients and share relevant content and investing in paid search ads to drive traffic to your website, you can increase your online visibility, build brand awareness, and drive more business. Business tips for creative entrepreneurs! While building a robust referral network remains a cornerstone of law firm business development, how you handle the inbound traffic matters just as much. Digital marketing offers a wide range of tools and strategies that can help law firms reach their target audience effectively and efficiently. Columbia Law List connects thousands of law firms with millions of debt collection files every year. On the downside, Law Ruler is pretty expensive, especially if you want to upgrade it or add more users to the system.